Chronic inflammatory demyelinating polyradiculoneuropathy: A role for haematopoietic stem cell transplantation?

References

• Austin JH. Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain 1958; 81(2)157–192
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Lais AC, Ohta M, et al. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975; 50(11)621–637
   PubMed Web of Science ®Google Scholar
• Prineas JW, McLeod JG. Chronic relapsing polyneuritis. J Neurol Sci 1976; 27(4)427–458
   PubMed Web of Science ®Google Scholar
• McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain 1987; Pt 6(110)1617–1630
   Google Scholar
• Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989; 46(8)878–884
   PubMedGoogle Scholar
• Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41(5)617–618
   PubMedGoogle Scholar
• Nicolas G, Maisonobe T, Le Forestier N, et al. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002; 25(1)26–30
   PubMed Web of Science ®Google Scholar
• Van den Bergh PY, Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004; 29(4)565–574
   PubMed Web of Science ®Google Scholar
• Lunn MP, Manji H, Choudhary PP, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: A prevalence study in south east England. J Neurol Neurosurg Psychiatry 1999; 66(5)677–680
   PubMed Web of Science ®Google Scholar
• McLeod JG, Pollard JD, Macaskill P, et al. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales. Australia Ann Neurol 1999; 46(6)910–913
   PubMedGoogle Scholar
• Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 2001; 8(2)157–165
   PubMedGoogle Scholar
• Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982; 9(32)958–964
   Google Scholar
• Simmons Z, Albers JW, Bromberg MB, Feldman EL. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain 1995; 118(Pt 2)359–368
   PubMedGoogle Scholar
• Bouchard C, Lacroix C, Plante V, et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999; 52(3)498–503
   PubMed Web of Science ®Google Scholar
• Prineas JW. Demyelination and remyelination in recurrent idiopathic polyneuropathy. An electron microscope study. Acta Neuropathol 1971; 18(1)34–57
   PubMedGoogle Scholar
• Maurer M, Gold R. Animal models of immune-mediated neuropathies. Curr Opin Neurol 2002; 15(5)617–622
   PubMed Web of Science ®Google Scholar
• Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002; 125(Pt 12)2591–2625
   PubMed Web of Science ®Google Scholar
• Allen D, Giannopoulos K, Gray I, et al. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2005; 10(2)174–180
   PubMed Web of Science ®Google Scholar
• Melendez-Vasquez C, Redford J, Choudhary PP, et al. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 1997; 73(1-2)124–134
   PubMed Web of Science ®Google Scholar
• Van den Berg LH, Mollee I, Wokke JH, Logtenberg T. Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy: Further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases. J Neuroimmunol 1995; 58(1)37–42
   PubMedGoogle Scholar
• Hu W, Janke A, Ortler S, et al. Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies. Neurology 2007; 68(4)277–282
   PubMed Web of Science ®Google Scholar
• Misawa S, Kuwabara S, Mori M, et al. Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy. Neurology 2001; 56(5)666–669
   PubMedGoogle Scholar
• Mei FJ, Ishizu T, Murai H, et al. Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF. J Neurol Sci 2005; 228(1)75–85
   PubMedGoogle Scholar
• Kieseier BC, Tani M, Mahad D, et al. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: A central role for IP-10. Brain 2002; 125(Pt 4)823–834
   PubMedGoogle Scholar
• Meyer zu Horste G, Hu W, Hartung HP, et al. The immunocompetence of Schwann cells. Muscle Nerve 2008; 37(1)3–13
   PubMedGoogle Scholar
• Dyck PJ, O'Brien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982; 11(2)136–141
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Daube J, O'Brien P, et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986; 314(8)461–465
   PubMed Web of Science ®Google Scholar
• Hahn AF, Bolton CF, Pillay N, et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain 1996; 119(Pt 4)1055–1066
   PubMedGoogle Scholar
• Hahn AF, Bolton CF, Zochodne D, Feasby TE. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 1996; 119(Pt 4)1067–1077
   PubMedGoogle Scholar
• Mendell JR, Barohn RJ, Freimer ML, et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001; 56(4)445–449
   PubMed Web of Science ®Google Scholar
• van Doorn PA, Brand A, Strengers PF, et al. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, crossover study. Neurology 1990; 40(2)209–212
   PubMed Web of Science ®Google Scholar
• Dyck PJ, O'Brien P, Swanson C, et al. Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy. Neurology 1985; 35(8)1173–1176
   PubMed Web of Science ®Google Scholar
• Fialho D, Chan YC, Allen DC, et al. Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate. J Neurol Neurosurg Psychiatry 2006; 77(4)544–547
   PubMed Web of Science ®Google Scholar
• Brannagan TH, Pradhan A, Heiman-Patterson T, et al. High-dose cyclophosphamide without stem-cell rescue for refractory CIDP. Neurology 2002; 58(12)1856–1858
   PubMed Web of Science ®Google Scholar
• Good JL, Chehrenama M, Mayer RF, Koski CL. Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy. Neurology 1998; 51(6)1735–1738
   PubMed Web of Science ®Google Scholar
• Barnett MH, Pollard JD, Davies L, McLeod JG. Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1998; 21(4)454–460
   PubMed Web of Science ®Google Scholar
• Hefter H, Sprenger KB, Arendt G, Hafner D. J Neurol 1990; 237(5)320–323
   PubMedGoogle Scholar
• Mahattanakul W, Crawford TO, Griffin JW, et al. Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A. J Neurol Neurosurg Psychiatry 1996; 60(2)185–187
   PubMedGoogle Scholar
• Umapathi T, Hughes R. Mycophenolate in treatment-resistant inflammatory neuropathies. Eur J Neurol 2002; 9(6)683–685
   PubMedGoogle Scholar
• Radziwill AJ, Schweikert K, Kuntzer T, et al. Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study. Eur Neurol 2006; 56(1)37–38
   PubMed Web of Science ®Google Scholar
• Hirst C, Raasch S, Llewelyn G, Robertson N. Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H). J Neurol Neurosurg Psychiatry 2006; 77(6)800–802
   PubMed Web of Science ®Google Scholar
• Choudhary PP, Thompson N, Hughes RA. Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 1995; 242(4)252–253
   PubMed Web of Science ®Google Scholar
• Hadden RD, Sharrack B, Bensa S, et al. Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1999; 53(1)57–61
   PubMed Web of Science ®Google Scholar
• Marmont AM. New horizons in the treatment of autoimmune diseases: Immunoablation and stem cell transplantation. Annu Rev Med 2000; 51: 115–134
   PubMed Web of Science ®Google Scholar
• van Gelder M, Kinwel-Bohre EP, van Bekkum DW. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 1993; 11(3)233–241
   PubMed Web of Science ®Google Scholar
• Ikehara S, Yasumizu R, Inaba M, et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A 1989; 86(9)3306–3310
   PubMedGoogle Scholar
• Snowden JA, Patton WN, O'Donnell JL, et al. Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 1997; 19(12)1247–1250
   PubMed Web of Science ®Google Scholar
• Jacobs P, Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant 1986; 1(2)237–239
   PubMedGoogle Scholar
• McAllister LD, Beatty PG, Rose J. Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis. Bone Marrow Transplant 1997; 19(4)395–397
   PubMed Web of Science ®Google Scholar
• Muraro PA, Douek DC, Packer A, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201(5)805–816
   PubMed Web of Science ®Google Scholar
• Vermeulen M, Van Oers MH. Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002; 72(1)127–128
   PubMed Web of Science ®Google Scholar
• Vermeulen M, van Oers MH. Relapse of chronic inflammatory demyelinating polyneuropathy 5 years after autologous stem cell transplantation. J Neurol Neurosurg Psychiatry 2007; 78(10)1154
   PubMed Web of Science ®Google Scholar
• Barreira A, Marques WJ, Rezende C, et al. Autologous stem cell transplantation of a patient with chronic inflammatory neuropathy and persistent conduction block. J Peripher Nerv Syst 2007; 12(s1)7
   Google Scholar
• Mahdi-Rogers M, Hughes R, Kazmi M, Ferner R. Autologous peripheral blood progenitor cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System 2007; 12(s1)55
   Google Scholar